miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy

Wenjun Yin(Central South University), HE Xiu-sheng(University of South China)
Oncology Reports
May 19, 2015
Cited by 38


Related Papers